Warby Parker (WRBY) Depreciation & Amortization (CF) (2020 - 2026)
Warby Parker (WRBY) reported Depreciation & Amortization (CF) of $13.8 million for Q1 2026, up 13.21% on a YoY basis from $12.2 million in Q1 2025, and up 5.09% quarter-over-quarter from $13.1 million in Q4 2025.
Warby Parker (WRBY) Depreciation & Amortization (CF) (2020 - 2026) Analysis & Trends
Warby Parker has reported Depreciation & Amortization (CF) for 7 years, with the latest figure at $13.8 million in Q1 2026.
- For the quarter ending Q1 2026, Depreciation & Amortization (CF) rose 13.21% year-over-year to $13.8 million; the trailing twelve-month figure through Mar 2026 stood at $39.1 million (down 17.65% YoY), and the FY2025 full-year result was $50.3 million, up 9.63% from the prior year.
- Depreciation & Amortization (CF) for Q1 2026 stood at $13.8 million, up from $13.1 million in the prior quarter.
- The five-year high for Depreciation & Amortization (CF) was $13.8 million in Q1 2026, with the low at $2.9 million in Q2 2023.
- Historically, Depreciation & Amortization (CF) has averaged $8.9 million across 5 years, with a median of $9.1 million in 2023.
- Annual changes were most pronounced in 2024 — Depreciation & Amortization (CF) jumped 279.87% — and 2025, when it sank 70.55%.
- Warby Parker's Depreciation & Amortization (CF) stood at $8.9 million in 2022, then rose by 16.29% to $10.4 million in 2023, then increased by 18.92% to $12.3 million in 2024, then grew by 6.24% to $13.1 million in 2025, then grew by 5.09% to $13.8 million in 2026.
- The last three Depreciation & Amortization (CF) figures came in at $13.8 million (Q1 2026), $13.1 million (Q4 2025), and $3.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 178.90 Mn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 563.00 Mn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 254.00 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 58.98 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 44.60 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 135.00 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 95.40 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 56.55 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 237.00 Mn |
| 10 | Warby Parker | 3.11 Bn | 2.82 Bn | 131.04 Mn | 13.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 13.77 Mn |
| Mar 31, 2026 | 13.77 Mn |
| Dec 31, 2025 | 13.10 Mn |
| Dec 31, 2025 | 13.10 Mn |
| Sep 30, 2025 | 3.48 Mn |
| Sep 30, 2025 | 3.48 Mn |
| Jun 30, 2025 | 8.72 Mn |
| Jun 30, 2025 | 8.72 Mn |
| Mar 31, 2025 | 12.16 Mn |
| Mar 31, 2025 | 12.16 Mn |
| Dec 31, 2024 | 12.33 Mn |
| Dec 31, 2024 | 12.33 Mn |
| Sep 30, 2024 | 11.83 Mn |
| Sep 30, 2024 | 11.83 Mn |
| Jun 30, 2024 | 11.12 Mn |
| Jun 30, 2024 | 11.12 Mn |
| Mar 31, 2024 | 10.58 Mn |
| Mar 31, 2024 | 10.58 Mn |
| Dec 31, 2023 | 10.37 Mn |
| Dec 31, 2023 | 10.37 Mn |